8-K
Conexeu Sciences Inc. Announces Warrant Exercise Inducement Program
8-K
Private Placement Raises $4.75 Million Through Units and Special Warrants, Including Common Shares and Two-Year Warrants
8-K
Conexeu Sciences Inc. Reports Unregistered Sales of Equity Securities Totaling 1,448,368 Shares and 202,500 Warrants
8-K
Conexeu Sciences Completes 12-Month Preclinical P.R.O.O.F Study for CXU™ Tissue-Restoration Platform
8-K
Conexeu Sciences Inc. Announces Warrant Exercises and Incentive Program Results
8-K
Conexeu Sciences Inc. Announces Warrant Exercises, Incentive Program Results, and Bylaw Amendment
